da Silva Gonçalves Bos Denielli, Happé Chris, Schalij Ingrid, Pijacka Wioletta, Paton Julian F R, Guignabert Christophe, Tu Ly, Thuillet Raphaël, Bogaard Harm-Jan, van Rossum Albert C, Vonk-Noordegraaf Anton, de Man Frances S, Handoko M Louis
Department of Pulmonology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, the Netherlands.
Department of Physiology VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, the Netherlands.
JACC Basic Transl Sci. 2017 Feb 1;2(1):22-35. doi: 10.1016/j.jacbts.2016.09.007. eCollection 2017 Feb.
Neurohormonal overactivation plays an important role in pulmonary hypertension (PH). In this context, renal denervation, which aims to inhibit the neurohormonal systems, may be a promising adjunct therapy in PH. In this proof-of-concept study, we have demonstrated in 2 experimental models of PH that renal denervation delayed disease progression, reduced pulmonary vascular remodeling, lowered right ventricular afterload, and decreased right ventricular diastolic stiffness, most likely by suppression of the renin-angiotensin-aldosterone system.
神经激素过度激活在肺动脉高压(PH)中起重要作用。在这种情况下,旨在抑制神经激素系统的肾去神经支配可能是PH中有前景的辅助治疗方法。在这项概念验证研究中,我们在2种PH实验模型中证明,肾去神经支配延缓了疾病进展,减少了肺血管重塑,降低了右心室后负荷,并降低了右心室舒张硬度,最有可能是通过抑制肾素-血管紧张素-醛固酮系统实现的。